4-[(1-Pyrrolidinylsulfonyl) methyl]aniline CAS 334981-10-1 Purity >99.0% (HPLC) Almotriptan Aniline Praecursor Factory
Ruifu Chemical Supple Almotriptan Malate Intermedia:
Almotriptan Malate CAS 181183-52-8
1-((4-Hydrazinylbenzyl)sulfonyl)pyrrolidinum hydrochloridum CAS 334981-11-2
4-[(1-Pyrrolidinylsulfonyl) methyl]aniline CAS 334981-10-1
1-[(4-Nitrophenylmethyl)sulfonyl]pyrrolidine CAS 340041-91-0
4-Chlorobutyraldehyde Diethyl Acetal CAS 6139-83-9
Nomen chemicum | 4-[(1-Pyrrolidinylsulfonyl) methyl]aniline |
Synonyma | 1-[(4-Aminobenzyl)sulfonyl]pyrrolidine;Almotriptan Aniline Praecursor |
CAS Number | 334981-10-1 |
CATTUS Number | RF-PI1948 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C11H16N2O2S |
M. Pondus | 240.32 |
Liquescens punctum | 170.0 ad 176.0℃ |
Density | 1.31 |
Solubilitas | Leviter solutum in Toluene |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | White deficere Yellow Crystalline pulveris |
Puritas / Analysis Methodus | >99.0% (HPLC) |
Damnum in Siccatio | <0.50% |
Residere in Ignition | <0.50% |
Max Single immunitas | <0.50% |
Totalis immunditias | <1.00% |
Metalla gravis | <20ppm |
Infrared Imaginis | Conformat ut Structure |
NMR | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Almotriptan Aniline Praecursor |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
4-[(1-Pyrrolidinylsulfonyl)methyl]aniline (CAS: 334981-10-1) est medium in praeparatione Malatis Almotriptan (CAS: 181183-52-8), Almotriptan Aniline Praecursor.Almotriptan Malate est genus medicamenti triptani, quod adhiberi potest ad capitis cephalea curationem.Almotriptan pertinet ad categoriam medicamentorum agonistarum selectivi serotonin receptoris.Almotriptan altam et proprietatem habet pro receptoribus serotonin 5-HT, ulteriorem ducens ad vascoconstrictionem cerebri vas sanguinis et discrimen sanguinis fluxum afficiens.Hi effectus desinunt signa doloris ex mitti in cerebrum, et ulterius suppressa emissione quarundam substantiarum naturalium, quae dolorem, nauseam et alia cephalea signa inducunt.Autem, Almotriptan impetus cephalea non impedit.Almotriptan, in 2000 venales, summam oralbioavailability inter omnes triptans habet.Almotriptan metabolized ab utroque MAO-A et CYP3A4 est, sic effectus profile cum Sumatriptano aequiores effectus habet.